Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model
- 1 December 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Behavioural Pharmacology
- Vol. 17 (8), 703-713
- https://doi.org/10.1097/fbp.0b013e3280116e5c
Abstract
To confirm the antidepressant-like activity of agomelatine (S 20098), a melatonin agonist and 5-hydroxytryptamine2C antagonist, already reported in the chronic mild stress and forced swimming tests, the effects of agomelatine were investigated in the learned helplessness test and compared with those of imipramine, melatonin and a selective 5-hydroxytryptamine2C antagonist, SB-242 084. Agomelatine was administered for 5 days either once a day or twice a day, and the effects of pretreatment by a melatonin receptor antagonist, S 22153 (20 mg/kg/day), were studied. A deficit in avoidance learning was observed in helpless control animals. Agomelatine (10 mg/kg/day) administered once a day significantly reduced this deficit with an effect similar to that of imipramine. Effects of agomelatine were abolished by S 22153 pretreatment. Melatonin or SB-242 084 did not reduce the deficit of helpless control animals. These results confirm the antidepressant-like activity of agomelatine and suggest a role of melatonin receptors in its mechanism of action.Keywords
This publication has 48 references indexed in Scilit:
- Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brainNeuropharmacology, 2004
- Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT 2C receptors in Wistar ratsPsychopharmacology, 2003
- Altered Editing of Serotonin 2C Receptor Pre-mRNA in the Prefrontal Cortex of Depressed Suicide VictimsNeuron, 2002
- Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the ratSynapse, 2000
- Characterisation of human melatonin mt1 and MT2 receptors by CRE-luciferase reporter assayEuropean Journal of Pharmacology, 2000
- Melatonin for the Treatment of Sleep Disturbances in Major Depressive DisorderAmerican Journal of Psychiatry, 1998
- Melatonin as a Therapeutic Agent in the Treatment of Sleep Disturbance in DepressionThe Journal of Nervous & Mental Disease, 1997
- Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)Pharmacology Biochemistry and Behavior, 1993
- Reversal of helpless behavior in rats by putative 5-HT1A agonistsBiological Psychiatry, 1988
- Negative effects of melatonin on depressionAmerican Journal of Psychiatry, 1976